HOOKIPA Pharma Inc. 和 Poolbeg Pharma (POLB) 可能合并创建临床阶段生物制药公司，专注于创新药物的开发和商业化

HOOKIPA Pharma Inc. 和 Poolbeg Pharma (POLB) 董事会宣布，他们已进入不具约束力的讨论

HOOKIPA Pharma (NASDAQ: HOOK) and Poolbeg Pharma (POLB) (NASDAQ: POLB) boards announced they have entered into non-binding discussions for an all-share acquisition by HOOKIPA of Poolbeg to create a clinical-stage biopharmaceutical company.

HOOKIPA Pharma（纳斯达克股票代码：HOOK）和 Poolbeg Pharma (POLB)（纳斯达克股票代码：POLB）董事会宣布，他们已就 HOOKIPA 收购 Poolbeg 的全部股份以创建一家临床阶段的生物制药公司进行不具约束力的讨论。

The combined entity will be focused on developing and commercialising innovative medicines for critical unmet medical needs, with a special focus on next-generation immunotherapies for the treatment of cancer and other serious diseases.

合并后的实体将专注于开发和商业化创新药物，以满足关键的未满足的医疗需求，特别关注用于治疗癌症和其他严重疾病的下一代免疫疗法。

In connection with the Potential Combination, HOOKIPA is expected to undertake a 100% primary private placement fundraise of up to approximately $30 million, which will be funded into HOOKIPA immediately following the completion of the Potential Combination.

关于潜在合并，HOOKIPA 预计将进行高达约 3000 万美元的 100% 主要私募融资，这笔资金将在潜在合并完成后立即注入 HOOKIPA。

The proceeds from the private placement will be used to provide sufficient capital for the enlarged business to realise meaningful expected value inflection points.

私募所得款项将用于为扩大后的业务提供充足的资金，以实现有意义的预期价值拐点。

Coinsilium Group (COIN) (AQUIS: COIN), the Web3 investor, advisor, and venture builder, has entered into a strategic collaboration agreement with investment portfolio company Otomato Inc, a pioneering Web3 technology platform specialising in autonomous agent-based solutions.

Web3 投资者、顾问和风险创建者 Coinsilium Group (COIN)（AQUIS：COIN）已与投资组合公司 Otomato Inc 签订战略合作协议，Otomato Inc 是一家专注于基于自主代理的解决方案的领先 Web3 技术平台。

The Collaboration aims to leverage Otomato’s cutting edge technologies to maximise the return potential of Coinsilium’s existing and future digital asset treasury holdings.

此次合作旨在利用 Otomato 的尖端技术，最大限度地提高 Coinsilium 现有和未来数字资产库存的回报潜力。

Given that the market is currently shining a light on COIN, and crypto, it makes sense for it to press ahead on an area which arguably will be the picks and shovels of what will happen next in the digital space: Web3.

鉴于市场目前对 COIN 和加密货币的关注度很高，因此推进一个可以说是数字空间接下来将发生的事情的领域：Web3 是有意义的。

Quadrise (QED), a supplier of innovative energy solutions for a cleaner planet, announced the signature of an agreement between the European Climate, Infrastructure and Environment Executive Agency and SEASTARS, a consortium of 17 companies which includes Quadrise.

Quadrise (QED) 是一家为清洁地球提供创新能源解决方案的供应商，宣布欧洲气候、基础设施和环境执行机构与 SEASTARS 签署协议。SEASTARS 是一个由 17 家公司组成的财团，其中包括 Quadrise。

QED said it was delighted to have joined the SEASTARS consortium, which will demonstrate the benefits of bioMSAR™ and our Blend-On-Board technology to a much wider audience, whilst our participation in the Horizon project will deepen our combined knowledge in this important area of marine decarbonisation.

QED 表示很高兴加入 SEASTARS 联盟，该联盟将向更广泛的受众展示 bioMSAR™ 和我们的 Blend-On-Board 技术的优势，同时我们参与 Horizo​​n 项目将加深我们在这一重要领域的综合知识海洋脱碳。

Although something of a filler RNS, QED is nevertheless reminding us that this autumn was transformational for the company both fundamentally and in terms of the share price, and that the momentum is set to continue.

尽管 QED 有点像 RNS 的填充物，但它仍然提醒我们，今年秋天对公司来说无论是基本面还是股价都发生了转变，而且这种势头将持续下去。

Contango Holdings (CGO), a company focused on unlocking value from the +2 billion tonne Muchesu coal project in Zimbabwe, has confirmed it has now received its first royalty payment of US$200,000 and expects to receive a further US$800,000 this month.

Contango Holdings (CGO) 是一家致力于释放津巴布韦超过 20 亿吨的 Muchesu 煤炭项目价值的公司，该公司已确认现已收到第一笔 20 万美元的特许权使用费，并预计本月将进一步收到 80 万美元。

Combined these will bring total royalty receipts to US$1,000,000 as envisaged and previously reported under the Mineral Royalty Agreement.

这些合计将使特许权使用费收入总额达到 1,000,000 美元，正如《矿产特许权使用费协议》中所设想和之前报告的那样。

CGO said this milestone marks a significant step forward in unlocking the immense value of the Muchesu coal project.

CGO表示，这一里程碑标志着在释放穆切苏煤炭项目巨大价值方面向前迈出了重要一步。

The receipt of our first royalty payment not only underscores the confidence our partners have in the project’s potential but also reinforces our commitment to delivering consistent value for our shareholders. With the operational foundations now firmly in place, we are excited about the continued progress and growth opportunities ahead.

我们收到第一笔特许权使用费不仅强调了我们的合作伙伴对该项目潜力的信心，而且强化了我们为股东提供一致价值的承诺。随着运营基础现已牢固就位，我们对未来的持续进步和增长机会感到兴奋。

Celadon Pharmaceuticals (CEL), a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines, has updated on its financial position.

Celadon Pharmaceuticals (CEL) 是一家总部位于英国的制药公司，专注于突破性大麻药物的开发、生产和销售，该公司更新了其财务状况。

The Company can confirmed the provider of the Committed Credit Facility has now transferred an additional £147k under the Company £1m draw down request.

公司可以确认承诺信贷融资的提供者现已根据公司 100 万英镑的提款请求额外转移了 14.7 万英镑。

The Company expects to receive the remaining £103k that is outstanding under the draw down during January 2025.

公司预计将在 2025 年 1 月期间收到未提取的剩余 10.3 万英镑。

While we know from Tesco that “Every Little Helps”, what we do not quite know is how CEL’s dribs and drabs will payments help its overall situation, or whether this is too little too late?

虽然我们从Tesco那里知道“一点一滴都有帮助”，但我们不太清楚光大控股的点点滴滴的付款将如何帮助其整体状况，或者这是否太少太晚了？

To directly support and accelerate the Company’s global licensing and partnership strategy to bring its non-invasive, cost effective, CIZ1B biomarker lung cancer blood test to market in 2025, Cizzle Biotechnology (CIZ), the UK based diagnostics developer, has announced that Professor Dawn Coverley, Founder and Non-Executive Director of Cizzle Biotechnology has, with immediate effect, been appointed Chief Scientific Officer, an executive role on the board of the Company.

为了直接支持和加速公司的全球许可和合作伙伴战略，以便于 2025 年将其非侵入性、成本效益高的 CIZ1B 生物标志物肺癌血液检测推向市场，英国诊断开发商 Cizzle Biotechnology (CIZ) 宣布，Dawn 教授Cizzle Biotechnology 创始人兼非执行董事 Coverley 已被任命为首席科学官，即公司董事会的执行职务，立即生效。

While we congratulate the professor on her new role, the main thing that the company has needed since it came to market is an evangelist for the cause, to explain to the market the investment proposition and the importance of what it is doing. Only then will CIZ attain a serious valuation.

虽然我们祝贺这位教授的新角色，但该公司自进入市场以来最需要的是一名宣传者，向市场解释投资主张及其正在做的事情的重要性。只有这样，CIZ 才会获得严肃的估值。

Emmerson (EML), the Moroccan focused potash development company, has announced that it has signed a Capital Provision Agreement with a specialist litigation funding firm to provide up to US$11,000,000 in both litigation finance capital and working capital for the Company (the “Funding”) and has confirmed Boies Schiller Flexner LLP as its litigation counsel.

专注于摩洛哥钾肥开发的公司艾默生 (EML) 宣布，已与一家专业诉讼融资公司签署了一份资本拨备协议，为公司提供最多 11,000,000 美元的诉讼融资资本和营运资本（“资金”） ）并已确认 Boies Schiller Flexner LLP 为其诉讼律师。

The Company has also put a Management Incentive Plan into place.

公司还制定了管理层激励计划。

After allegedly getting ripped

据称被撕毁后